|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 15-08-04 | Hospira : Pfizer wins EU approval for $15 billion Hospira buy | RE |
| 15-07-27 | Allergan : Mylan independence from Teva's embrace comes with a price | RE |
Company details: Hospira, Inc.
Group companies: Hospira, Inc.
| Name | Category and Sector |
|---|---|
Hospira UK Ltd.
 Hospira UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products |
Pharmaceuticals: Major
|
Generic Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.11% | -3.32% | +17.96% | +64.97% | 47.73B | |
| -1.06% | -5.77% | +37.73% | +115.68% | 40.21B | |
| -1.58% | -3.46% | +11.66% | +79.48% | 12.05B | |
| -1.51% | -4.21% | -11.56% | +9.52% | 11.79B | |
| +0.38% | -1.32% | +21.40% | +137.27% | 9.16B | |
| 0.00% | -4.04% | +21.19% | +33.90% | 7.34B | |
| -2.95% | -5.33% | +32.45% | -15.96% | 7.39B | |
| -1.60% | -1.43% | +18.67% | +213.45% | 7.37B | |
| +1.32% | -1.19% | -46.13% | +22.77% | 5.13B | |
| Average | -0.90% | -1.95% | +11.49% | +73.45% | 16.46B | |
| Weighted average by Cap. | -1.05% | -2.67% | +19.37% | +80.31% |
- Stock Market
- Stocks
- Stock
- Company Hospira, Inc.
Select your edition
All financial news and data tailored to specific country editions
